Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Linkage to Care After HBV Diagnosis in Asian Communities in the US

A discussion of barriers to linkage to care after patients in Asian communities are diagnosed with HBV, from the healthcare provider’s and the patient advocate’s perspectives.
Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Tram T. Tran, MD
person default
Thuan Vu, MD
Jennifer Wild, MS, BSN, RN, OCN
Released: November 14, 2022

This episode is part of a larger discussion that comes from “Partnering With Patients: Overcoming Barriers to HBV Care in Asian Communities in the US.” Hear from Thuan Vu, MD, as he discusses linkage to care after HBV diagnosis in Asian communities from a provider’s perspective. And listen to discussions with Jennifer Wild, MSN, BSN, RN, OCN, and Melinda Tran as they consider his story from a patient advocacy point of view.

Topics include barriers to linkage to care like social stigma, lack of insurance coverage, financial support, and a lack of physicians who speak the patient’s native language.

Information on this Educational Activity

Faculty

Thuan Vu, MD
Thuan Vu, MD, has no relevant financial relationships to disclose.
Tram T. Tran, MD

Medical Director of Liver Transplant
Comprehensive Transplant Center
Cedars Sinai Medical Center
Professor of Medicine
Division of Gastroenterology
Geffen UCLA School of Medicine
Los Angeles, California

Melinda Tran has no relevant financial relationships to disclose.
Jennifer Wild, MS, BSN, RN, OCN
Jennifer Wild, MS, BSN, RN, OCN: consultant/advisor/speaker: MUH Life Sciences.
Mindie H. Nguyen, MD, MAS, AGAF, FAASLD

Professor of Medicine
Department of Gastroenterology and Hepatology
Stanford University Medical Center
Palo Alto, California

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD: consultant/advisor/speaker: Exact Science, Gilead, GlaxoSmithKline, Intercept, Laboratory of Advanced Medicine, Lilly; researcher: Exact Science, Gilead, GlaxoSmithKline, Intercept, Laboratory of Advanced Medicine, Lilly.

Program Medium

This program has been made available online.

Acknowledgements

Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Supported by an educational grant from:
Gilead Sciences, Inc.

Related Content

Dr Maria Buti shares strategies to ensure patients with HBV are promptly screened for HDV, from Clinical Care Options (CCO)

Maria Buti, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: January 12, 2023 Expired: January 11, 2024

Download this slideset on overcoming barriers in HDV screening, from Clinical Care Options (CCO)

Maria Buti, MD Released: January 5, 2023

Learn from Dr Nancy Reau why we may want to challenge current guidelines on HDV screening, from Clinical Care Options (CCO)

Nancy Reau, MD Released: January 5, 2023

Dr Tatyana Kushner provides special considerations in diagnosing HDV through a patient case, from Clinical Care Options (CCO)

Tatyana Kushner, MD, MSCE Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: December 21, 2022 Expired: December 20, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings